Certification Rate
99.3%
Very high DOL cert
2026 data Public-data reference Official source
Boehringer Ingelheim Pharmaceuticals, Inc.
A DOL Labor Condition Application record spanning FY2023–2026. Review the filing volume, DOL certification record, and offered-wage context below.
- DOL LCA filings
- 142
- DOL-certified
- 99.3%
- Median offered wage
- $149,302
Ridgefield, CT NAICS: 325412
How many H-1B LCA filings list Boehringer Ingelheim Pharmaceuticals, Inc.?
U.S. Department of Labor's OFLC discloses 142 Labor Condition Application filings naming Boehringer Ingelheim Pharmaceuticals, Inc. from FY2023 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
How many H-1B petitions has USCIS approved for Boehringer Ingelheim Pharmaceuticals, Inc.?
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 79 H-1B petitions naming Boehringer Ingelheim Pharmaceuticals, Inc. through FY2024, and approved the large majority of them: 96.2% approved (76 approvals, 3 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
The verdict
Boehringer Ingelheim Pharmaceuticals, Inc. is listed in 142 DOL LCA filings, among the largest employer filers by filing volume in this extract. DOL certified 99.3% of those LCAs; the median listed offered wage is $149,302. This is not a USCIS approval, hiring, or sponsorship ranking.
- 142
- DOL LCA filings, FY2023–FY2026
- 99.3%
- DOL-certified
- $149,302
- median offered wage
- Top 1%
- of employer filers by volume
According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2026). Based in Ridgefield, CT.
Boehringer Ingelheim Pharmaceuticals, Inc. LCA outcome mix
142DOL LCA filings on record
Saved on this device only, no account, no email.
Open saved list
Follow this profile's data updates
Updates when the published DOL data vintage changes; this is a feed, not an alert service.
Boehringer Ingelheim Pharmaceuticals, Inc. vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
142 1726th of 122824 higher than 121,098 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2023–FY2026
LCA filing shape · Boehringer Ingelheim Pharmaceuticals, Inc.
Derived from this employer's disclosed LCAs on file (FY2023–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $75,000–$425,596 .
Title concentration
- Senior Scientist 18 · 12.7% · $129,184
- Senior Clinical Data Scientist 17 · 12% · $141,150
- Principal Clinical Data Scientist 9 · 6.3% · $167,604
- Post Doctoral Fellow 5 · 3.5% · $80,000
- Senior Scientist, Process Research 4 · 2.8% · $123,250
Worksite counties
- FAIRFIELD, CT 72 · 88.9%
- RIDGEFIELD, CT 6 · 7.4%
- DANBURY CITY, CT 3 · 3.7%
DOL LCA release change
What changed between the two LCA fiscal years
- Boehringer Ingelheim Pharmaceuticals, Inc.'s disclosed H-1B LCA filing count rose from 42 in FY2024 to 46 in FY2025 (+9.5%).
- Boehringer Ingelheim Pharmaceuticals, Inc.'s average disclosed H-1B offered wage rose from $140,424 in FY2024 to $159,561 in FY2025 (+13.6%).
National-scale filing footprint
Boehringer Ingelheim Pharmaceuticals, Inc. has filed 142 LCAs (more volume than 99% of U.S. employer filers in this extract). DOL certification: 99.3%. Worksites span 1 state , led by CT.
Above-prevailing wage posture
On 142 LCAs with comparable offered vs prevailing wages, Boehringer Ingelheim Pharmaceuticals, Inc. averages about 18.4% above the prevailing wage (national baseline ≈ 17.8%). Dominant PW level on file: Fully Competent (Level IV) (33.1% of LCA filings).
Fairfield, CT worksite concentration
Only 142 LCAs on file for Boehringer Ingelheim Pharmaceuticals, Inc., and 79.6% land in FAIRFIELD, CT. Treat rates as descriptive of a small sample. DOL cert on file: 99.3%.
Avg. Salary
$149,302
Above portal avg
Total Workers
142
Moderate worker count
Compare with another employer filer
Boehringer Ingelheim Pharmaceuticals, Inc. vs a peer vs the national average, from DOL LCA data.
Avg. offered wage$149,302 · 35% higher than Yale University
This filer
Peer
$110,467
National avg.
$113,357
Certification rate99.3% · about the same as Yale University
This filer
Peer
99.3%
National avg.
97.7%
Total LCA filings142 · 90% lower than Yale University
This filer
Peer
1,455
National avg.
17
FY2025 filings are 107% of FY2023
43 completed-year filings in FY2023, 46 in FY2025. The scale spans up to twice the earlier year's count: the midpoint is unchanged and the endpoint is at least doubled.
Wondering how long it takes USCIS to process an H-1B petition for this employer?
See current I-129 processing times →
Salary Analysis
Compensation range for H-1B positions at Boehringer Ingelheim Pharmaceuticals, Inc.
Minimum
$75,000
Maximum
$425,596
Average Salary
$149,302
LCA Filing History
H-1B LCA filing trends from FY2023 to FY2026
FY2023 43 LCA filings · 100% DOL-certified · $142,883 avg
FY2024 42 LCA filings · 100% DOL-certified · $140,424 avg
FY2025 46 LCA filings · 97.8% DOL-certified · $159,561 avg
FY2026 is partial on this extract. Chart shows completed fiscal years only (through FY2025).
Top Occupations
Most frequently listed job titles at Boehringer Ingelheim Pharmaceuticals, Inc.
| Job Title | LCA filings | Avg. Salary |
|---|---|---|
| Senior Scientist | 18 | $129,184 |
| Senior Clinical Data Scientist | 17 | $141,150 |
| Principal Clinical Data Scientist | 9 | $167,604 |
| Post Doctoral Fellow | 5 | $80,000 |
| Senior Scientist, Process Research | 4 | $123,250 |
| Senior Clinical Data Engineer | 4 | $131,181 |
| SENIOR CLINICAL DATA SCIENTIST | 4 | $153,692 |
| Principal Scientist | 4 | $154,787 |
| Scientist II | 3 | $85,688 |
| Clinical Data Scientist | 3 | $103,667 |
| Trial Clinical Pharmacologist | 2 | $131,043 |
| Senior Scientist, MAS | 2 | $122,351 |
| Senior Scientist, Computational Biology (Expert) | 2 | $144,863 |
| Scientist IV, Drug Metabolism & Pharmacokinetics | 2 | $120,000 |
| Scientist III | 2 | $106,165 |
Geographic Distribution
Where Boehringer Ingelheim Pharmaceuticals, Inc. places H-1B workers across the United States
CT 100 LCA filings
Nationwide peers near Boehringer Ingelheim Pharmaceuticals, Inc.'s 142-LCA band
Cross-state DOL neighbors for Boehringer Ingelheim Pharmaceuticals, Inc. - LCA filing-count and offered-wage axes, outside CT.
Similar LCA filing volume
Nearest cross-state employer filers by LCA filing count (142 here; floor ≥10 LCA filings).
Similar avg offered wage
Cross-state employer filers with a comparable average listed offered wage ($149,302 here).
Disclaimer: Informational only, not professional advice.
Read with Boehringer Ingelheim Pharmaceuticals, Inc.
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MID-BOOK · CERT-CLEAN · WAGE-PREMIUM.
Chicago Public Schools · MID-BOOK
ABS(total_petitions) peer at 142 LCAs (Δ 0 heavier vs Boehringer Ingelheim Pharmaceuticals, Inc.); CERT-CLEAN · WAGE-BELOW vs this page's MID-BOOK · CERT-CLEAN · WAGE-PREMIUM.
Humetis Technologies, Inc. · MID-BOOK
ABS(total_petitions) peer at 142 LCAs (Δ 0 heavier vs Boehringer Ingelheim Pharmaceuticals, Inc.); CERT-LOCK · WAGE-BELOW vs this page's MID-BOOK · CERT-CLEAN · WAGE-PREMIUM.
James Madison University · MID-BOOK
ABS(total_petitions) peer at 142 LCAs (Δ 0 heavier vs Boehringer Ingelheim Pharmaceuticals, Inc.); CERT-CLEAN · WAGE-BELOW vs this page's MID-BOOK · CERT-CLEAN · WAGE-PREMIUM.
JNIT Technologies, Inc · MID-BOOK
ABS(total_petitions) peer at 142 LCAs (Δ 0 heavier vs Boehringer Ingelheim Pharmaceuticals, Inc.); CERT-CLEAN · WAGE-PAR vs this page's MID-BOOK · CERT-CLEAN · WAGE-PREMIUM.
Yale University · LARGEST-distance pole
CT pole at 1,455 LCAs stamps HEAVY-BOOK · CERT-CLEAN, farthest ABS(total_petitions) contrast from Boehringer Ingelheim Pharmaceuticals, Inc.'s MID-BOOK.
CT worksite board · MID-BOOK
Open the CT state board after the ABS peers. Boehringer Ingelheim Pharmaceuticals, Inc. stamps MID-BOOK · CERT-CLEAN inside that worksite mix.
Salary calculator · WAGE-PREMIUM
Boehringer Ingelheim Pharmaceuticals, Inc.'s WAGE-PREMIUM offered-wage posture needs occupation/state context, not a shared guide card.
What to do with this profile
Use the DOL LCA record for Boehringer Ingelheim Pharmaceuticals, Inc. to compare filing volume and offered wages, not USCIS outcomes.
- Boehringer Ingelheim Pharmaceuticals, Inc. filed 142 LCAs in the indexed extract (99.3% certified in-file). That places it among the largest employer filers by volume in this extract.
- Compare offered wages and certification rates against 6 same-state filers on the chart above. Jump to compare
- See how other employers in CT rank on LCA filing volume this vintage. CT filers
- Read what an LCA filing records versus a USCIS petition approval. LCA vs petition
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.